Detalhe da pesquisa
1.
Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer.
Gynecol Oncol
; 178: 27-35, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748268
2.
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study.
Gynecol Oncol
; 169: 64-69, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512912
3.
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
Int J Gynecol Cancer
; 32(12): 1576-1582, 2022 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368707
4.
Targeting obesity-related dysfunction in hormonally driven cancers.
Br J Cancer
; 125(4): 495-509, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33911195
5.
Bevacizumab in advanced endometrial cancer.
Gynecol Oncol
; 161(3): 720-726, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894982
6.
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
Gynecol Oncol
; 160(1): 71-76, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139041
7.
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
Cancer
; 126(6): 1274-1282, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880826
8.
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecol Oncol
; 156(1): 194-202, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31757464
9.
Optimizing immunotherapy for gynecologic cancers.
Curr Opin Obstet Gynecol
; 32(1): 1-8, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833942
10.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
Nat Med
; 30(5): 1330-1338, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653864
11.
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
Clin Cancer Res
; 28(19): 4302-4311, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849120
12.
Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma.
Gynecol Oncol Rep
; 37: 100844, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34430690
13.
Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer.
Gynecol Oncol Rep
; 38: 100873, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34926756
14.
Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness.
Clin Case Rep
; 8(2): 289-292, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128175
15.
Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation.
J Gastrointest Oncol
; 8(6): 1051-1055, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29299366